Hello, Guest
Login
Sign Up
 
 

Notable Buzz: Goldman Sachs, Apple Inc.(NASDAQ:AAPL), US Airways, Oncolytics Biotech

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 02/25/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Goldman Sachs (GS) plans to begin a fresh round of job cuts commencing as early as this week, reports Reuters. Thinning of the herd by about 5% is typical at this time of the year for Goldman, and it's likely the equities side will face larger cuts than fixed income (the opposite of last year).

How Should Investors Trade GS After The Recent Movement? Find Out Here

Apple Inc.(NASDAQ:AAPL) newfound success in India could provide a template for attacking emerging markets where the iPhone's high unsubsidized prices have limited sales. Payment plans - one promotion involves a $93 up-front payment for an $840 iPhone 5 - have grown Apple's addressable market, a splashy ad campaign has increased brand awareness, and new distributor deals have expanded reach. Canalys estimates Dec. quarter Indian iPhone sales nearly tripled Q/Q to 250K, but Apple's 5% local smartphone share is still well behind Samsung's 40%.

Is AAPL A Strong Buy After The Recent Fall? Get Free Trend Analysis Here

US Airways (LCC -2.9%) exec Scott Kirby and restructuring specialist Beverly Goulet of American Airlines (AAMRQ.PK) have been tapped to lead post-merger planning teams. In addition, the companies will hire an outside merger management to assist the process. The big picture: Analysts have been warning that if the integration process doesn't go smoothly, synergies from the mega-deal will be much harder to realize.

Is LCC a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten public offering of 8M shares at $4. The company intends to use the net proceeds from the offering to fund its clinical trial and manufacturing program.

How Should Investors Trade ONCY After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.